Very low birth weight neonates who survive early-onset sepsis do not have an increased risk of developing late-onset sepsis

Early Human Development

Volumn 88, Issue 11, 2012, Pages 905-909

  Lin, Cheryl B ^a,b   Hornik, Christoph P ^b,c   Clark, Reese ^d   Cotten, C Michael ^b   Benjamin, Daniel K ^b,c   Cohen Wolkoweiz, Michael ^b,c   Smith, P Brian ^b,c   Wynn, James L ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d Pediatrix Obstetrix Center for Research and Education   (United States)

Author keywords

Immunoparalysis; Neonate; Preterm; Sepsis

Indexed keywords

ANTIMICROBIAL THERAPY; APGAR SCORE; ARTICLE; CANDIDA; COHORT ANALYSIS; EARLY ONSET SEPSIS; ENTEROBACTER; ESCHERICHIA COLI; ETHNICITY; FEMALE; GESTATIONAL AGE; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA; LATE ONSET SEPSIS; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DEATH; NEWBORN MORTALITY; NEWBORN SEPSIS; ONSET AGE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; TREATMENT DURATION; VERY LOW BIRTH WEIGHT;

AGE OF ONSET; FEMALE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; RISK FACTORS; SEPSIS;

EID: 84866859333     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2012.07.009     Document Type: Article

References (27)

1. Stoll B.J., Hansen N.I., Bell E.F., Shankaran S., Laptook A.R., Walsh M.C., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126:443-456.
2. Landelle C., Lepape A., Français A., Tognet E., Thizy H., Voirin N., et al. Nosocomial infection after septic shock among intensive care unit patients. Infect Control Hosp Epidemiol 2008, 29:1054-1065.
3. Frazier W.J., Hall M.W. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008, 55:647-668. [xi].
4. Wynn J.L., Neu J., Moldawer L.L., Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 2009, 29:79-88.
5. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
6. Leviton A., Dammann O., Engelke S., Allred E., Kuban K.C., O'Shea T.M., et al. The clustering of disorders in infants born before the 28th week of gestation. Acta Paediatr 2010, 99:1795-1800.
7. Strunk T., Doherty D., Jacques A., Simmer K., Richmond P., Kohan R., et al. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2012, 129:e134-e141.
8. Cohen-Wolkowiez M., Moran C., Benjamin D.K., Cotten C.M., Clark R.H., Benjamin D.K., et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J 2009, 28:1052-1056.
9. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
10. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
11. MacLean L.D., Meakins J.L., Taguchi K., Duignan J.P., Dhillon K.S., Gordon J. Host resistance in sepsis and trauma. Ann Surg 1975, 182:207-217.
12. Hall M.W., Knatz N.L., Vetterly C., Tomarello S., Wewers M.D., Volk H.D., et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 2011, 37:525-532.
13. Sanchez-Schmitz G., Levy O. Development of newborn and infant vaccines. Sci Transl Med 2011, 3. [90ps27].
14. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
15. Birle A., Nebe C.T., Gessler P. Age-related low expression of HLA-DR molecules on monocytes of term and preterm newborns with and without signs of infection. J Perinatol 2003, 23:294-299.
16. Genel F., Atlihan F., Ozsu E., Ozbek E. Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. J Infect 2010, 60:224-228.
17. Wynn J., Cornell T.T., Wong H.R., Shanley T.P., Wheeler D.S. The host response to sepsis and developmental impact. Pediatrics 2010, 125:1031-1041.
18. Strunk T., Currie A., Richmond P., Simmer K., Burgner D. Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 2011, 24:25-31.
19. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L., et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009, 133:228-237.
20. Corbett N.P., Blimkie D., Ho K.C., Cai B., Sutherland D.P., Kallos A., et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS One 2010, 5:e15041.
21. Kollmann T.R., Crabtree J., Rein-Weston A., Blimkie D., Thommai F., Wang X.Y., et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009, 183:7150-7160.
22. Wynn J.L., Cvijanovich N.Z., Allen G.L., Thomas N.J., Freishtat R.J., Anas N., et al. The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 2011, 17:1146-1156.
23. Carson W.F., Cavassani K.A., Dou Y., Kunkel S.L. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics 2011, 6:273-283.
24. Wynn J.L., Scumpia P.O., Winfield R.D., Delano M.J., Kelly-Scumpia K., Barker T., et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008, 112:1750-1758.
25. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M., et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. J Infect Dis 2011, 204:245-252.
26. Lisciandro J.G., van den Biggelaar A.H. Neonatal immune function and inflammatory illnesses in later life: lessons to be learnt from the developing world?. Clin Exp Allergy 2010, 40:1719-1731.
27. Lukacs S.L., Schrag S.J. Clinical sepsis in neonates and young infants, United States, 1988-2006. J Pediatr 2012, 160:960-965. [e1].